Lymphatic metastasis in the absence of functional intratumor lymphatics - PubMed (original) (raw)
. 2002 Jun 7;296(5574):1883-6.
doi: 10.1126/science.1071420. Epub 2002 Apr 25.
Ananth Kadambi, Emmanuelle di Tomaso, Carla Mouta Carreira, Edward B Brown, Yves Boucher, Noah C Choi, Douglas Mathisen, John Wain, Eugene J Mark, Lance L Munn, Rakesh K Jain
Affiliations
- PMID: 11976409
- DOI: 10.1126/science.1071420
Lymphatic metastasis in the absence of functional intratumor lymphatics
Timothy P Padera et al. Science. 2002.
Abstract
Lymphatic metastasis contributes to mortality from solid tumors. Whether metastasizing cancer cells reach lymph nodes via intratumor lymphatic vessels is unknown. Here, we examine functional lymphatics associated with mouse tumors expressing normal or elevated levels of vascular endothelial growth factor-C (VEGF-C), a molecule that stimulates lymphangiogenesis. Although VEGF-C overexpression increased lymphatic surface area in the tumor margin and lymphatic metastasis, these tumors contained no functional lymphatics, as assessed by four independent functional assays and immunohistochemical staining. These findings suggest that the functional lymphatics in the tumor margin alone are sufficient for lymphatic metastasis and should be targeted therapeutically.
Comment in
- Cancer. Targeting lymphatic metastasis.
Gershenwald JE, Fidler IJ. Gershenwald JE, et al. Science. 2002 Jun 7;296(5574):1811-2. doi: 10.1126/science.10731318. Science. 2002. PMID: 12052939 No abstract available.
Similar articles
- Cancer. Targeting lymphatic metastasis.
Gershenwald JE, Fidler IJ. Gershenwald JE, et al. Science. 2002 Jun 7;296(5574):1811-2. doi: 10.1126/science.10731318. Science. 2002. PMID: 12052939 No abstract available. - Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO. Wong SY, et al. Cancer Res. 2005 Nov 1;65(21):9789-98. doi: 10.1158/0008-5472.CAN-05-0901. Cancer Res. 2005. PMID: 16267000 - Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z, Scholz A, Stacker SA, Achen MG, Jackson DG, Alves F, Schirner M, Haberey M, Thierauch KH, Wiedenmann B, Rosewicz S. Von Marschall Z, et al. Int J Oncol. 2005 Sep;27(3):669-79. Int J Oncol. 2005. PMID: 16077915 - Molecular control of lymphatic metastasis.
Achen MG, Stacker SA. Achen MG, et al. Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020. Ann N Y Acad Sci. 2008. PMID: 18519975 Review. - Lymphangiogenesis and tumor metastasis: myth or reality?
Pepper MS. Pepper MS. Clin Cancer Res. 2001 Mar;7(3):462-8. Clin Cancer Res. 2001. PMID: 11297234 Review.
Cited by
- Lymphatic system regulation of anti-cancer immunity and metastasis.
Lei PJ, Fraser C, Jones D, Ubellacker JM, Padera TP. Lei PJ, et al. Front Immunol. 2024 Aug 15;15:1449291. doi: 10.3389/fimmu.2024.1449291. eCollection 2024. Front Immunol. 2024. PMID: 39211044 Free PMC article. Review. - Lymphatic vessels in the age of cancer immunotherapy.
Karakousi T, Mudianto T, Lund AW. Karakousi T, et al. Nat Rev Cancer. 2024 Jun;24(6):363-381. doi: 10.1038/s41568-024-00681-y. Epub 2024 Apr 11. Nat Rev Cancer. 2024. PMID: 38605228 Review. - Orthotopic model for the analysis of melanoma circulating tumor cells.
Pícková M, Kahounová Z, Radaszkiewicz T, Procházková J, Fedr R, Nosková M, Radaszkiewicz KA, Ovesná P, Bryja V, Souček K. Pícková M, et al. Sci Rep. 2024 Apr 3;14(1):7827. doi: 10.1038/s41598-024-58236-y. Sci Rep. 2024. PMID: 38570556 Free PMC article. - Homodimeric peptide radiotracer [68Ga]Ga-NOTA-(TMVP1)2 for VEGFR-3 imaging of cervical cancer patients.
Chen X, Zhang Z, Wang L, Zhang J, Zhao T, Cai J, Dang Y, Guo R, Liu R, Zhou Y, Wei R, Lou X, Xia F, Ma D, Li F, Dai J, Li F, Xi L. Chen X, et al. Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2338-2352. doi: 10.1007/s00259-024-06661-6. Epub 2024 Feb 27. Eur J Nucl Med Mol Imaging. 2024. PMID: 38411667 - Quantitative multiplex immunohistochemistry reveals inter-patient lymphovascular and immune heterogeneity in primary cutaneous melanoma.
Femel J, Hill C, Illa Bochaca I, Booth JL, Asnaashari TG, Steele MM, Moshiri AS, Do H, Zhong J, Osman I, Leachman SA, Tsujikawa T, White KP, Chang YH, Lund AW. Femel J, et al. Front Immunol. 2024 Feb 1;15:1328602. doi: 10.3389/fimmu.2024.1328602. eCollection 2024. Front Immunol. 2024. PMID: 38361951 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous